Patent ID: 9717682
Date: 2017-08-01
CPC Classifications: A61K,A61P

Claim:
1. An oral film dosage form that maintains a plurality of active ingredient particles in an effective particle size range to maintain reduced structural order, and/or improve solubility and bioavailability of the active, comprising: at least one pharmaceutically active ingredient in the form of amorphous particles that are capable of existing in crystalline form; at least one primary crystallization inhibitor present in an amount that inhibits crystallization, growth and agglomeration of the amorphous particles of the pharmaceutically active ingredient; propylene glycol caprylate in an amount that further enhances inhibition of crystallization, growth and agglomeration of the amorphous particles of the pharmaceutically active ingredient; and at least one plasticizer present in an amount that is effective to increase flexibility and elasticity of the film dosage form.